Nifty
Sensex
:
:
24471.70
78154.25
-112.10 (-0.46%)
-388.19 (-0.49%)

Pharmaceuticals & Drugs - Veterinary

Rating :
72/99

BSE: 512529 | NSE: VIYASH

261.45
11-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  274.9
  •  279
  •  256.3
  •  273.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6709993
  •  1781835510.65
  •  298
  •  167.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 11,501.38
  • 67.20
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,667.49
  • N/A
  • 4.21

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 61.31%
  • 4.55%
  • 20.52%
  • FII
  • DII
  • Others
  • 4.5%
  • 2.93%
  • 6.19%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.47
  • 19.34
  • 35.67

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 31.27
  • 42.93
  • 60.43

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 34.05
  • 396.47

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 54.96
  • 68.79
  • 122.78

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.95
  • 5.41
  • 6.22

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 44.58
  • 60.01
  • 72.78

Earnings Forecasts:

(Updated: 08-08-2026)
Description
2026
2027
2028
2029
Adj EPS
78
13
-
-
P/E Ratio
3.35
20.11
-
-
Revenue
34.77
26.11
19.89
-
EBITDA
-
-
-
-
Net Income
-
-
-
-
ROA
392.8
523
686.3
-
P/B Ratio
-
-
-
-
ROE
3.97
3.67
3.64
-
FCFF
13.2
15.3
19
-
FCFF Yield
-
-
-
-
Net Debt
-
-
-
-
BVPS
-
-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
946.36
791.64
19.54%
919.96
772.31
19.12%
858.41
774.03
10.90%
423.99
368.65
15.01%
Expenses
767.98
672.87
14.13%
735.71
659.43
11.57%
682.78
674.29
1.26%
368.31
329.55
11.76%
EBITDA
178.38
118.77
50.19%
184.25
112.88
63.23%
175.63
99.74
76.09%
55.68
39.10
42.40%
EBIDTM
18.85%
15.00%
20.03%
14.62%
20.46%
12.89%
13.13%
10.61%
Other Income
8.31
6.84
21.49%
15.92
10.22
55.77%
13.98
6.66
109.91%
2.15
4.51
-52.33%
Interest
12.51
20.43
-38.77%
14.52
20.68
-29.79%
16.75
20.64
-18.85%
13.51
14.29
-5.46%
Depreciation
61.77
55.59
11.12%
60.41
64.73
-6.67%
58.53
58.39
0.24%
15.46
17.10
-9.59%
PBT
112.41
48.34
132.54%
125.24
-36.66
-
73.07
24.48
198.49%
27.16
7.90
243.80%
Tax
33.12
11.49
188.25%
58.86
-4.48
-
24.55
-17.46
-
7.56
1.56
384.62%
PAT
79.29
36.85
115.17%
66.38
-32.18
-
48.52
41.94
15.69%
19.60
6.34
209.15%
PATM
8.38%
4.65%
7.22%
-4.17%
5.65%
5.42%
4.62%
1.72%
EPS
1.51
1.27
18.90%
1.19
-1.05
-
0.88
1.78
-50.56%
0.59
0.10
490.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
3,148.72
3,420.31
3,006.84
1,369.73
1,420.91
1,412.82
1,361.62
1,179.24
1,039.31
847.84
683.57
Net Sales Growth
16.33%
13.75%
119.52%
-3.60%
0.57%
3.76%
15.47%
13.46%
22.58%
24.03%
 
Cost Of Goods Sold
1,451.11
1,562.73
1,470.18
759.74
833.77
793.00
694.65
605.05
543.01
462.17
356.70
Gross Profit
1,697.61
1,857.58
1,536.66
609.98
587.14
619.82
666.96
574.19
496.30
385.67
326.87
GP Margin
53.91%
54.31%
51.11%
44.53%
41.32%
43.87%
48.98%
48.69%
47.75%
45.49%
47.82%
Total Expenditure
2,554.78
2,767.78
2,622.84
1,308.32
1,408.95
1,303.43
1,151.68
1,008.92
914.37
764.87
640.62
Power & Fuel Cost
-
105.89
103.57
35.46
42.45
33.86
28.75
24.73
23.06
14.66
12.77
% Of Sales
-
3.10%
3.44%
2.59%
2.99%
2.40%
2.11%
2.10%
2.22%
1.73%
1.87%
Employee Cost
-
565.50
551.97
250.57
258.38
231.37
187.22
165.06
145.95
113.83
106.22
% Of Sales
-
16.53%
18.36%
18.29%
18.18%
16.38%
13.75%
14.00%
14.04%
13.43%
15.54%
Manufacturing Exp.
-
212.25
202.63
73.58
86.95
93.67
96.18
83.24
77.73
59.07
57.63
% Of Sales
-
6.21%
6.74%
5.37%
6.12%
6.63%
7.06%
7.06%
7.48%
6.97%
8.43%
General & Admin Exp.
-
168.53
151.82
78.10
75.80
66.90
58.40
56.37
58.35
57.35
48.60
% Of Sales
-
4.93%
5.05%
5.70%
5.33%
4.74%
4.29%
4.78%
5.61%
6.76%
7.11%
Selling & Distn. Exp.
-
100.37
88.42
56.70
58.00
57.11
50.00
45.16
36.29
36.87
28.78
% Of Sales
-
2.93%
2.94%
4.14%
4.08%
4.04%
3.67%
3.83%
3.49%
4.35%
4.21%
Miscellaneous Exp.
-
52.51
54.25
54.16
53.60
27.52
36.47
29.32
29.98
20.93
28.78
% Of Sales
-
1.54%
1.80%
3.95%
3.77%
1.95%
2.68%
2.49%
2.88%
2.47%
4.38%
EBITDA
593.94
652.53
384.00
61.41
11.96
109.39
209.94
170.32
124.94
82.97
42.95
EBITDA Margin
18.86%
19.08%
12.77%
4.48%
0.84%
7.74%
15.42%
14.44%
12.02%
9.79%
6.28%
Other Income
40.36
43.55
35.82
10.96
6.39
10.86
10.49
10.09
8.67
16.59
11.08
Interest
57.29
69.21
86.37
48.09
35.52
15.77
24.38
35.71
32.80
33.07
28.34
Depreciation
196.17
233.64
238.71
61.54
55.69
51.54
50.60
50.62
41.92
41.34
40.07
PBT
337.88
393.23
94.74
-37.26
-72.86
52.93
145.45
94.08
58.88
25.15
-14.39
Tax
124.09
124.37
-2.59
-25.03
-15.68
8.17
32.18
12.03
2.01
13.46
-0.53
Tax Rate
36.73%
35.63%
-19.65%
45.80%
11.39%
15.44%
23.55%
12.79%
3.41%
56.91%
3.68%
PAT
213.79
177.28
23.22
-35.87
-121.16
40.95
95.44
69.91
48.66
0.93
-11.30
PAT before Minority Interest
171.16
224.65
15.77
-29.61
-121.98
44.76
104.45
82.05
56.88
10.19
-13.86
Minority Interest
-42.63
-47.37
7.45
-6.26
0.82
-3.81
-9.01
-12.14
-8.22
-9.26
2.56
PAT Margin
6.79%
5.18%
0.77%
-2.62%
-8.53%
2.90%
7.01%
5.93%
4.68%
0.11%
-1.65%
PAT Growth
303.76%
663.48%
-
-
-
-57.09%
36.52%
43.67%
5,132.26%
-
 
EPS
4.89
4.06
0.53
-0.82
-2.77
0.94
2.18
1.60
1.11
0.02
-0.26

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
2,911.06
2,431.59
656.56
698.78
692.10
727.65
687.10
706.69
647.58
976.79
Share Capital
87.37
50.06
49.89
49.89
49.67
49.67
49.67
49.37
48.75
48.75
Total Reserves
2,617.78
2,201.61
529.37
592.57
595.33
670.21
623.34
638.43
581.25
912.49
Non-Current Liabilities
484.39
439.77
172.55
175.81
209.11
153.58
216.46
214.75
227.13
246.20
Secured Loans
300.25
349.13
123.76
113.95
87.25
62.52
108.88
126.94
85.14
141.76
Unsecured Loans
1.84
3.77
18.96
36.16
35.21
31.18
41.18
20.90
18.40
23.38
Long Term Provisions
40.31
32.85
72.22
21.47
55.95
27.19
13.16
30.50
28.54
34.76
Current Liabilities
945.90
1,015.11
645.54
558.76
537.35
513.11
514.86
440.41
430.93
545.32
Trade Payables
597.27
489.33
251.22
244.34
258.05
226.91
220.38
209.35
160.49
203.04
Other Current Liabilities
187.34
286.43
118.60
109.57
78.99
100.64
104.98
87.80
106.52
141.04
Short Term Borrowings
121.52
204.17
245.87
182.09
159.54
102.91
147.12
127.36
152.41
194.70
Short Term Provisions
39.77
35.18
29.86
22.76
40.77
82.66
42.38
15.90
11.51
6.54
Total Liabilities
4,545.02
4,019.82
1,531.05
1,483.76
1,486.57
1,443.00
1,463.16
1,402.10
1,342.62
1,785.53
Net Block
2,102.95
2,103.19
591.95
605.31
564.44
535.66
576.57
498.14
475.97
684.33
Gross Block
3,521.94
3,277.04
959.12
939.83
825.09
753.25
762.46
638.06
581.74
789.60
Accumulated Depreciation
1,418.99
1,173.85
367.17
334.52
260.64
217.60
185.89
139.91
105.77
105.27
Non Current Assets
2,290.47
2,208.49
689.64
693.88
678.16
676.33
738.86
795.99
804.61
1,176.02
Capital Work in Progress
70.46
43.40
15.93
55.28
11.63
30.79
13.42
22.61
18.04
32.55
Non Current Investment
0.02
0.02
0.89
0.01
36.79
76.94
131.29
179.65
221.73
363.97
Long Term Loans & Adv.
32.15
40.62
69.47
21.74
53.97
32.15
16.74
33.09
32.42
37.51
Other Non Current Assets
84.89
21.27
11.41
11.54
11.32
0.79
0.84
62.49
56.44
57.66
Current Assets
2,254.55
1,782.79
829.49
779.79
808.41
766.68
724.30
606.12
538.01
594.41
Current Investments
0.05
0.07
2.61
0.05
1.44
5.66
40.18
0.47
17.34
64.12
Inventories
803.20
682.23
346.23
346.09
347.97
264.36
219.42
200.10
158.57
160.81
Sundry Debtors
1,045.23
806.47
335.63
340.96
329.24
346.14
318.76
278.25
258.35
254.62
Cash & Bank
269.70
157.19
69.83
41.75
59.25
56.20
75.83
72.04
42.45
47.40
Other Current Assets
136.36
31.72
10.37
7.74
70.51
94.34
70.12
55.26
61.30
67.46
Short Term Loans & Adv.
117.87
105.11
64.81
43.21
62.83
77.52
55.33
46.75
56.05
54.48
Net Current Assets
1,308.65
767.67
183.95
221.03
271.06
253.57
209.44
165.71
107.08
49.08
Total Assets
4,545.02
3,991.28
1,519.13
1,473.67
1,486.57
1,443.01
1,463.16
1,402.11
1,342.62
1,770.43

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
322.91
344.80
30.59
16.81
30.59
114.75
115.33
116.02
45.24
-7.19
PBT
349.02
13.18
-54.65
-137.66
52.93
145.45
94.08
58.88
445.79
-16.80
Adjustment
364.38
454.63
144.97
220.72
93.73
83.98
91.41
84.47
-313.85
123.31
Changes in Working Capital
-329.16
-74.15
-45.67
-51.61
-89.30
-70.89
-58.30
-27.95
-77.87
-104.37
Cash after chg. in Working capital
384.24
393.67
44.65
31.45
57.36
158.55
127.18
115.40
54.06
2.14
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-61.33
-48.87
-14.06
-14.64
-26.77
-43.79
-11.85
0.62
-8.83
-9.33
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-84.12
-447.21
-5.92
-64.96
-95.57
9.65
-72.27
-67.69
7.17
-116.18
Net Fixed Assets
-70.75
-1,752.24
20.87
1.33
-7.29
-4.18
-29.66
-32.63
221.87
-49.63
Net Investments
-8.99
-327.47
-7.89
26.09
26.57
72.52
30.56
-101.61
204.06
0.16
Others
-4.38
1,632.50
-18.90
-92.38
-114.85
-58.69
-73.17
66.55
-418.76
-66.71
Cash from Financing Activity
-123.33
87.03
-1.44
32.23
67.26
-138.75
-42.75
-20.08
-56.96
147.44
Net Cash Inflow / Outflow
115.46
-15.38
23.24
-15.92
2.29
-14.35
0.31
28.25
-4.55
24.07
Opening Cash & Equivalents
140.30
156.18
41.57
57.50
53.74
68.10
67.79
39.54
44.10
20.03
Closing Cash & Equivalent
255.76
140.30
64.81
41.57
57.50
53.74
68.10
67.79
39.54
44.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
61.92
89.96
23.22
25.76
25.97
28.98
27.10
27.86
25.85
39.44
ROA
5.25%
0.57%
-1.96%
-8.21%
3.06%
7.19%
5.73%
4.14%
26.54%
-0.95%
ROE
9.06%
1.11%
-4.85%
-18.95%
6.56%
15.00%
12.06%
8.63%
54.15%
-1.74%
ROCE
13.10%
4.80%
-0.60%
-9.71%
7.01%
16.24%
12.59%
9.24%
41.28%
0.87%
Fixed Asset Turnover
1.01
1.42
1.49
1.65
1.83
1.80
1.72
1.74
1.51
0.96
Receivable days
98.80
69.32
87.51
84.11
85.48
89.12
90.45
92.53
90.49
118.40
Inventory Days
79.26
62.42
89.54
87.10
77.50
64.84
63.56
61.85
56.34
78.37
Payable days
126.90
91.93
119.04
109.97
111.61
117.51
80.72
75.36
77.04
104.11
Cash Conversion Cycle
51.16
39.81
58.01
61.25
51.38
36.45
73.29
79.02
69.78
92.66
Total Debt/Equity
0.16
0.27
0.78
0.62
0.49
0.31
0.51
0.47
0.48
0.43
Interest Cover
6.04
1.15
-0.14
-2.88
4.36
6.60
3.63
2.80
12.19
0.41

News Update:


  • Viyash Scientific signs binding agreement to acquire 100% stake in BFL
    8th Jun 2026, 14:22 PM

    The transaction represents a significant step in its strategy to capitalize on the mega-trend of a growing companion Animal Health Generics market

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.